• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
GUO Yixuan,LIN Ang.Research progress of osteoarthritis therapy based on RNA technology[J].Journal Of Pharmaceutical Research,2025,44(11):1,091-1,097[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 1822times   Download 720次 QR Code for this article
Scan with your phone!
基于RNA技术的骨关节炎治疗研究进展
郭一轩1,2,林昂1,2
Font:Larger+|Default|Smaller-
(1.中国药科大学基础医学与临床药学学院,江苏 南京 211198;2.中国药科大学新药安排评价研究中心,江苏 南京 211198)
摘要:
骨关节炎(osteoarthritis,OA)是一种慢性退行性骨关节疾病,主要表现为关节部位的疼痛、肿大,严重影响患者的生活质量。目前临床用药选择有限,一线用药为非甾体抗炎药(NSAIDs)与皮质醇类药物,但只能提供短期的缓解效果,不能改变疾病进展。利用合成化学和生物学工具开发的基于工程化RNA为未来骨关节炎治疗提供了希望,这些疗法具有持久、有效的作用机制,可以专门针对病理的潜在驱动因素。本综述重点介绍了具有骨关节炎治疗潜力的基于RNA的新兴技术,包括用于基因沉默的siRNA,用于多基因调控的microRNA,用于基因补充的mRNA。总之,本文的目的在于揭示RNA相关技术可以为骨关节炎提供新的治疗手段。
关键词:  骨关节炎  RNA技术  siRNA  microRNA  mRNA  新型疗法
DOI:10.13506/j.cnki.jpr.2025.11.009
基金项目:国家自然科学基金面上项目(No.32471004)
Publication Date:November 25, 2025
Research progress of osteoarthritis therapy based on RNA technology
GUO Yixuan1,2,LIN Ang1,2
(1.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198,China;2.Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing 211198,China)
Abstract:
Osteoarthritis (OA) is a chronic degenerative bone disease, mainly manifested by joint pain and swelling that , seriously affect the quality of life. At present, the clinical medication options are limited. The first-line drugs are non-steroidal anti-inflammatory drugs (NSAIDs) and cortisol-based drugs, but they can only provide short-term relief effects and cannot change the progression of the disease. Engineered RNA-based therapies developed using synthetic chemistry and biological tools offer hope for future osteoarthritis treatments. These therapies have long-lasting and effective mechanisms of action and can specifically target the underlying drivers of pathology. In this brief review, we focus on emerging RNA-based technologies with therapeutic potential for OA, including siRNA for gene silencing, microRNA for polygenic regulation, and mRNA for gene supplementation. In conclusion, the purpose of this article is to reveal that RNA-related technologies can provide new treatment methods for osteoarthritis.
Key words:  Osteoarthritis  RNA technology  siRNA  microRNA  mRNA  Novel therapeutics
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.